Acumen Pharmaceuticals News

Acumen Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 22 22:19 ET

Acumen Pharmaceuticals | DEFA14A: Others

Apr 22 16:37 ET

Acumen Pharmaceuticals | DEF 14A: Definitive information statements

Apr 22 16:32 ET

Acumen Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Mar 27 16:40 ET

Acumen Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 27 16:06 ET

Acumen Pharmaceuticals | 10-K: Annual report

Mar 26 09:24 ET

Acumen Pharmaceuticals | 8-K: Current report

Mar 26 07:44 ET

Acumen Pharmaceuticals | 8-K: Current report

Mar 19 08:06 ET

Acumen Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.

Feb 14 08:36 ET

Acumen Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Franklin Resources, Inc.(5.8%),Franklin Advisers, Inc.(5.7%)

Feb 6 09:06 ET

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Doherty James J.

Feb 1 17:07 ET

Acumen Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Doherty James J.

Feb 1 17:03 ET

Acumen Pharmaceuticals | 8-K: Current report

Feb 1 07:21 ET

Acumen Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James B. Murray, Jr.(4.6%)

Jan 24 16:26 ET

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer OConnell Daniel Joseph

Jan 19 00:00 ET

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Meisner Derek M

Jan 19 00:00 ET

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zuga Matt

Jan 19 00:00 ET

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Siemers Eric

Jan 19 00:00 ET

Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Barton Russell

Jan 19 00:00 ET

Acumen Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 19 00:00 ET